NovaBay Pharmaceuticals, Inc. (NBY) Insider Trading -- Recent Executive & Director Transactions
10 insiders reported 11 Form 4 transactions for NovaBay Pharmaceuticals, Inc. (NBY) over the past 18 months (most recent 2026-01-29). Recent activity: Lazar David E. (10% Owner) Buy 6.4M shares, Kazley Michael John (Chief Executive Officer) Buy 56.8M shares, R01 Fund LP (Chief Executive Officer) Buy 56.8M shares, R01 Capital LLC (10% Owner) Buy 56.8M shares, R01 Capital Manager LLC (10% Owner) Buy 56.8M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-29 | Lazar David E. | 10% Owner | Buy | 6.4M | $0 |
| 2025-11-03 | Kazley Michael John | Chief Executive Officer | Buy | 56.8M | $0 |
| 2025-11-03 | R01 Fund LP | Chief Executive Officer | Buy | 56.8M | $0 |
| 2025-11-03 | R01 Capital LLC | 10% Owner | Buy | 56.8M | $0 |
| 2025-11-03 | R01 Capital Manager LLC | 10% Owner | Buy | 56.8M | $0 |
| 2025-11-03 | Kazley Michael John | 10% Owner | Buy | 56.8M | $0 |
| 2025-11-03 | Framework Ventures IV L.P. | 10% Owner | Buy | 56.8M | $0 |
| 2025-11-03 | Framework Ventures Management LLC | 10% Owner | Buy | 56.8M | $0 |
| 2025-11-03 | Spencer Vance | 10% Owner | Buy | 56.8M | $0 |
| 2025-11-03 | Framework Ventures IV GP LLC | 10% Owner | Buy | 56.8M | $0 |
| 2025-11-03 | Anderson Michael Ernest | 10% Owner | Buy | 56.8M | $0 |
Source: SEC Form 4 filings · as of 2026-01-29